The treatment for metastatic renal cell carcinoma / 中华泌尿外科杂志
Chinese Journal of Urology
;
(12): 474-476, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-869674
ABSTRACT
The prognosis of metastatic renal cell carcinoma is relatively poor. With the development of molecular biology, the treatment of metastatic renal cell carcinoma is undergoing a transformation from cytokine therapy to targeted molecular therapy or immunotherapy, and the prognosis has been improved. This study summarized and discussed the treatment progress of metastatic renal cell carcinoma.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Urology
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS